Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Gains from Sales and Divestitures (2017)

Historic Gains from Sales and Divestitures for Wave Life Sciences (WVE) over the last 1 years, with Q4 2017 value amounting to $205000.0.

  • Wave Life Sciences' Gains from Sales and Divestitures changed N/A to $205000.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $205000.0, marking a year-over-year change of. This contributed to the annual value of $205000.0 for FY2017, which is N/A changed from last year.
  • Latest data reveals that Wave Life Sciences reported Gains from Sales and Divestitures of $205000.0 as of Q4 2017.
  • In the past 5 years, Wave Life Sciences' Gains from Sales and Divestitures registered a high of $205000.0 during Q4 2017, and its lowest value of $205000.0 during Q4 2017.